Lower plasma DHEAS and BDNF levels as indicators of cognitive decline
- 3 January 2026
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 144, 111605
Abstract
No abstract availableKeywords
Funding Information
- Republic of Croatia Ministry of Science and Education
- Ministarstvo znanosti i obrazovanja
- Hrvatska Zaklada za Znanost (IP-2019-04-6100)
- Hrvatska Zaklada za Znanost (DOK-2021-02-2553)
- Hrvatska Zaklada za Znanost (DOK-2020-01-3622)
This publication has 111 references indexed in Scilit:
- The clock drawing test is an important contribution to the Mini Mental State Examination in screening for cognitive impairmentInternational Journal of Geriatric Psychiatry, 2023
- The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer’s disease: a 9-year follow-up studyEuropean Archives of Psychiatry and Clinical Neuroscience, 2019
- Impact of brain‐derived neurotrophic factor genetic polymorphism on cognition: A systematic reviewBrain and Behavior, 2018
- BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic PlasticityCellular and Molecular Neurobiology, 2017
- Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta‐analysisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009
- Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based CohortsArchives of Neurology, 2009
- Dehydroepiandrosterone and age-related cognitive declineAGE, 2009
- Stage-dependent BDNF serum concentrations in Alzheimer’s diseaseJournal of Neural Transmission, 2005
- Clock-drawing: is it the ideal cognitive screening test?International Journal of Geriatric Psychiatry, 2000
- Region-Specific Neurotrophin Imbalances in Alzheimer DiseaseArchives of Neurology, 2000